Patents
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
08/2006
08/03/2006WO2006017688A3 Combination therapy using transferrin fusion proteins comprising glp-1
08/03/2006WO2005123144A3 System and method for an automated synthesis of gallium-68 generator-based radiopharmaceutical agents
08/03/2006WO2005120483A3 Selective androgen receptor modulators and methods of use thereof
08/03/2006WO2005113011A3 Prodrugs of ion channel modulating compounds and uses thereof
08/03/2006US20060173282 Method for the production of hyperpolarized 129xe
08/03/2006US20060171885 Skin or hair binding peptides
08/03/2006US20060171884 Provide a higher affinity towards Matriptase; have a very low, or nonmeasurable, immunogenicity in humans
08/03/2006US20060171883 Detection, localization and staging of tumors using labeled activated lymphocytes directed to a tumor specific epitope
08/03/2006US20060171882 Method for the use of [11C] carbon monoxide in labeling synthesis of 11C-labelled compounds by thermally induced free radical carbonylation
08/03/2006US20060171881 Compounds with high monoamine transporter affinity
08/03/2006CA2595892A1 Ephb receptor-binding peptides
08/02/2006EP1685851A1 A method for the diagnosis of helicobacter pylori infection and diagnostic kit for performing the method
08/02/2006EP1685850A1 A method for the diagnosis of helicobacter pylori infection and diagnostic kit for performing the method
08/02/2006EP1684810A1 Polybiotin compounds for magnetic resonance imagining and drug delivery
08/02/2006EP1684809A1 Chelate based scaffolds in tumor targeting
08/02/2006EP1684804A2 Binding molecules for the extra-domain b of fibronectin, used for the detection of atherosclerotic plaques
08/02/2006EP1684580A2 Methods, compositions and devices for inducing stasis in tissues and organs
08/02/2006EP1684579A1 Methods, compositions and devices for inducing stasis in cells, tissues, organs, and organisms
08/02/2006EP1165137B1 Sphingomyelin containing preparation for the enhancement of tumor therapy
08/02/2006EP1058562B1 Compositions and methods of treating tumors
08/02/2006EP0730472B1 Immobilized labelling method
08/02/2006CN1812816A Prosthetic groups attached to stannyl polymer in the synthesis of radiopharmaceuticals
08/02/2006CN1812815A Tritiated growth hormone secretagogue MK-0677
08/02/2006CN1267451C Somatostatin analogues
08/01/2006US7083983 Inhibitors of the interaction between P53 and MDM2
07/2006
07/27/2006WO2006078914A1 Compounds having rd targeting motifs
07/27/2006WO2006078746A2 Method, compositions and classification for tumor diagnostics and treatment
07/27/2006WO2006047372A3 Lamotrigine analogs
07/27/2006WO2006030197A3 Radiolabelled insulin
07/27/2006WO2006008496A3 Improved n4 chelator conjugates
07/27/2006WO2004110339A3 Method for selective targeting of apoptotic cells and small molecule ligands used thereof
07/27/2006US20060167332 Method for preparing particles of radioactive powder containing cesium-131 for use in brachytherapy sources
07/27/2006US20060166982 Isotopically labelly indlinone derivatives and process for their preparation
07/27/2006US20060166892 Treatment of cell proliferative disorders with chlorotoxin
07/27/2006US20060165706 Antibodies against CTLA4 and uses therefor
07/27/2006US20060165701 Agents for the diagnosis and treatment of tumors that expose alerted proteins on the cell surface
07/27/2006US20060165680 Humanized anti-tag 72 cc49 for diagnosis and therapy of human tumors
07/27/2006US20060165678 Measuring changes in level of antigen recognizable by a monoclonal antibody or antigen binding fragment; monoclonal antibody is produced by hybridoma cell line; decreased level indicates a reduced tumor; diagnosis, cell purification
07/27/2006US20060165600 Backbone-substituted bifunctional dota ligands, complexes and compositions thereof, and methods of using same
07/27/2006US20060165596 Method and apparatus for noninvasively evaluating endothelial function
07/27/2006US20060165594 Preparation of m(co)3-complexes by solid phase techniques via metal assisted cleavage from the solid support
07/27/2006US20060165593 Tc and re labeler radioactive glycosylated octreotide derivatives
07/27/2006US20060165592 Nk cell receptor conjugates for treating malignancies
07/27/2006US20060165591 Metal complex-containing pharmaceutical agents
07/27/2006US20060165590 Method for the use of [11C] carbon monoxide in labeling synthesis of 11C-labelled esters by photo-induced free radical carbonylation
07/27/2006US20060163526 high pressure homogenization; high throughput screening
07/27/2006CA2595570A1 Laser activated nanothermolysis of cells
07/26/2006EP1683520A2 Water-soluble paclitaxel produgs
07/26/2006EP1682113A1 Inhibitor imaging agents
07/26/2006EP0929303B1 Cns-penetrant nk-1 receptor antagonists as antidepressant and/or an anti-anxiety agent
07/26/2006EP0637968B2 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING
07/25/2006US7081452 Diagnosis, therapy, image of celluloar disorders; antitumor agents
07/25/2006US7081239 Administering formulation comprising peptide YY or antagonists of receptors for peptide YY for manipulating the rate of upper gastrointestinal transit of a substance in a mammal having an intrinsic cholinergic afferent neural pathway
07/25/2006US7081238 Assessing the level of dopamine transporter in at least one region of the patient's central nervous system, by binding a dopamine transporter ligand to the dopamine transporters using tomography
07/20/2006WO2006076525A2 Combination cancer therapy with anti-psma antibodies
07/20/2006WO2006020743A3 Heat shock protein as a targeting agent for endothelium-specific in vivo transduction
07/20/2006US20060160997 Tumor-associated antigen specific immunoglobulin fusion for use in diagnosis, prevention and treatment of cell proliferative
07/20/2006US20060160901 Method for selective targeting of apoptotic cells and small molecule ligands used thereof
07/20/2006US20060160741 Dimeric TF antagonists
07/20/2006US20060160157 Method, compositions and classification for tumor diagnostics and treatment
07/20/2006US20060159683 Stabilization of chimeric immunoglobulin; obtain immunoglobulin, monitor structure, determine sequence, adjust amino acid sequences for greater stability
07/20/2006US20060159682 Monoclonal antibodies (MAbs) against tumor-associated antigens, the preparation and use thereof
07/20/2006US20060159620 Human kininogen D3 domain polypeptide as an anti-angiogenic and anti-tumor agent
07/20/2006US20060159619 Cell permeable nanoconjugates of shell-crosslinked knedel (SCK) and peptide nucleic acids ("PNAs") with uniquely expressed or over-expressed mRNA targeting sequences for early diagnosis and therapy of cancer
07/20/2006US20060159618 Preparation of compounds useful for the detection of hypoxia
07/20/2006US20060159617 Small technetium-99m and rhenium labeled agents and methods for imaging tissues, organs and tumors
07/20/2006US20060159616 Methods for detecting endocrine cancer
07/20/2006DE19507822B4 Substituierte DTPA-Monoamide der zentralen Carbonsäure und deren Metallkomplexe, diese Komplexe enthaltende pharmazeutische Mittel, deren Verwendung in der Diagnostik und Therapie sowie Verfahren zur Herstellung der Komplexe und Mittel Substituted DTPA-monoamides of central carboxylic acid and their metal complexes, pharmaceutical agents containing these complexes, their use in diagnostics and therapy and methods for preparing the complexes and agents
07/20/2006DE102004022200B4 Radium-Target sowie Verfahren zu seiner Herstellung Radium target, and process for its preparation
07/20/2006CA2593574A1 Combination cancer therapy with anti-psma antibodies
07/19/2006CN1805760A Thorium-227 for use in radiotherapy of soft tissue disease
07/19/2006CN1803198A Particle analog assistant for high-intensity focusing ultrasonic therapy and its uses
07/19/2006CN1264576C Method and equipment for on-line preparation of dopamine transport protein developer [IIC]-beta-CFT
07/18/2006US7078495 minimal cross reactivity with tacolimus metaolites; antibody is conjugated with a detectable label; sample reacted with an enzyme labelled tacrolimus analogue, total signal present is measured; test kits
07/18/2006US7078014 In vivo magnetic resonance imaging by intravenous injection of compounds such as porphyrins, chlorins, bacteriochlorins, and related tetra- pyrrolic compounds with radioactive elements such as Technetium99, Gadolinium, Indium111 and iodine
07/18/2006US7078013 Pretargeting methods and compounds
07/18/2006CA2195556C Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype
07/18/2006CA2190727C Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging
07/13/2006WO2006073586A2 Radiation dosimetry and blocking antibodies and methods and uses threfor in the treatment of cancer
07/13/2006WO2006072948A2 Gastro-retentive diagnostic assemblies
07/13/2006WO2006072596A1 6- (2 , 3 , 4 , 5-TETRAHYDRO-lH-BENZO [D] AZEPIN-7-YLOXY) -NICOTAMIDE DERIVATIVES AS RADIOLABELLED LIGANDS
07/13/2006WO2006072336A2 Radioactive metal complexes based on bispidine and derivatives thereof
07/13/2006WO2006038185A3 Use of the staudinger ligation in imaging and therapy end kits for imaging and therapy
07/13/2006US20060155120 Optically pure and enriched isomers of chelating ligands and contrast agents
07/13/2006US20060155107 SSTR1-selective analogs
07/13/2006US20060154989 For use as contrast media; x-ray diagnosis and magnetic resonance imaging
07/13/2006US20060153771 Preparations for measuring gastric emptying ability
07/13/2006US20060153770 Method of treating tumors
07/13/2006US20060151297 Clean room guided conveyor
07/13/2006CA2594383A1 6- (2 , 3 , 4 , 5-tetrahydro-lh-benzo [d] azepin-7-yloxy) -nicotamide derivatives as radiolabelled ligands
07/13/2006CA2593256A1 Conjugates for dual imaging and radiochemotherapy: composition, manufacturing, and applications
07/12/2006EP1679083A2 Use of metaloporphyrins for treatment of arteriosclerotic lesions
07/12/2006EP1677813A1 Angiogenic peptides and uses thereof
07/12/2006EP1677735A2 Methods and compositions for modulating adipocyte function
07/12/2006CN1263516C Medicine preparations for diagnosing helicobacter pyloni infection
07/11/2006US7074760 Bactericides; peptide antibiotics
07/11/2006US7074613 Monoclonal antibody directed against cells of human renal cell carcinoma
07/11/2006US7074408 Use of integrin antagonists to inhibit angiogenesis
07/11/2006US7074405 antibody binds target tissue and conjugate carrying epitope (haptens)
07/11/2006US7074403 Immunotherapy of autoimmune disorders using antibodies which target B-cells